Abstract:Ni Shi, * Hao Yu, * Tong Chen Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA *These authors contributed equally to this work Correspondence: Tong Chen Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, 410 West 12 th Ave., Room 302C, Columbus, Ohio 43210, USA Tel +1 614 685 9119 Fax +1 614 293 3349 Email tong.chen@osumc.edu Background: The phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway is implicated in several cancers. AKT allosteric inhibitor MK2206 and dual PI3K and mTOR inhibitor BEZ235 are promising drug candidates with potential anti-tumor effects. Purpose: In this study, we aimed to detect the activation of PI3K/AKT/mTOR pathway and assess the efficacy of MK2206 and BEZ235 in inhibiting esophageal cancer growth. Materials and methods: We used three different systems including carcinogen-induced animal model, human esophageal squamous cell carcinoma (SCC) cell lines, and xenograft mouse model. Results: Our data indicated that components of the PI3K/AKT/mTOR pathway were overexpressed and activated in esophageal SCC. MK2206 and BEZ235 inhibited cell proliferation, enhanced apoptosis, and induced cell-cycle arrest through downstream effectors SKP2, MCL-1, and cyclin D1 in esophageal SCC cells. MK2206 and BEZ235 also inhibited tumor growth in xenograft mice through the inhibition of AKT phosphorylation. MK2206/BEZ235 combination showed greater anti-tumor effect than MK2206 or BEZ235 alone. The enhanced efficacy of the combination was associated with the inhibition of phosphorylation ATK on both Thr308 and Ser473. Conclusion: The combination of MK2206 and BEZ235 exhibits potent antitumor effects and may have important clinical applications for esophageal SCC treatment. Keywords: PI3K/AKT/mTOR, MK2206, BEZ235, Esophageal squamous cell carcinoma

Thymoquinone Inhibits the Proliferation and Invasion of Esophageal Cancer Cells by Disrupting Theakt/gsk-3/Wnt Signaling Pathway Viaptenupregulation

Thymoquinone Augments Cisplatin-Induced Apoptosis on Esophageal Carcinoma Through Mitigating the Activation of JAK2/STAT3 Pathway

Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro

Thymoquinone induces apoptosis and protective autophagy in gastric cancer cells by inhibiting the PI3K/Akt/mTOR pathway

TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling

Thymoquinone Suppresses the Proliferation, Migration and Invasiveness through Regulating ROS, Autophagic Flux and miR-877-5p in Human Bladder Carcinoma Cells.

Thymoquinone Induces G2/M Arrest, Inactivates PI3K/Akt and Nuclear Factor-Κb Pathways in Human Cholangiocarcinomas Both in Vitro and in Vivo.

Proliferation and apoptosis effects of thymoquinone on human gastric cancer MGC-803 cells and its mechanism

Enhancing conventional chemotherapy drug cisplatin-induced anti-tumor effects on human gastric cancer cells both in vitro and in vivo by Thymoquinone targeting PTEN gene.

Thymoquinone Inhibits Growth and Augments 5-Fluorouracil-induced Apoptosis in Gastric Cancer Cells Both in Vitro and in Vivo

Thymoquinone Selectively Induces Hepatocellular Carcinoma Cell Apoptosis in Synergism with Clinical Therapeutics and Dependence of P53 Status.

Thymoquinone Inhibits the Migration and Invasive Characteristics of Cervical Cancer Cells SiHa and CaSki in Vitro by Targeting Epithelial to Mesenchymal Transition Associated Transcription Factors Twist1 and Zeb1

Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways.

Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo.

Triptolide prevents proliferation and migration of Esophageal Squamous Cell Cancer via MAPK/ERK signaling pathway

Thymoquinone Inhibits Metastatic Phenotype and Epithelial‑mesenchymal Transition in Renal Cell Carcinoma by Regulating the LKB1/AMPK Signaling Pathway.

Thymoquinone Inhibits Angiogenesis And Prostate Tumor Growth By Suppressing Mapk Signaling Pathways

Thymoquinone Inhibits the Metastasis of Renal Cell Cancer Cells by Inducing Autophagy Via AMPK/mTOR Signaling Pathway.

Thymoquinone Suppresses Invasion and Metastasis in Bladder Cancer Cells by Reversing EMT Through the Wnt/β-catenin Signaling Pathway

Inhibition of esophageal cancer growth through the suppression of PI3K/AKT/mTOR signaling pathway

Thymoquinone Induces Apoptosis in Bladder Cancer Cell Via Endoplasmic Reticulum Stress-Dependent Mitochondrial Pathway